SAN ANTONIO--(BUSINESS WIRE)--KCI announced today that its V.A.C.Ulta™ Therapy System and Prevena™ Incision Management System received new Innovative Technology designations from Novation, the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista.
The significant designation is only provided to a small portion of products that are already available on contract through Novation. As part of the recent Novation Innovative Technology Expo, the products were thoroughly evaluated and reviewed by hospital member-led councils and found to have an incremental benefit over other products that improve patient care or reduce the risk of harm to patients and care givers. The products are now designated with a new Innovative Technology icon in the Novation online contract catalog, making them easy to identify.
“The people of KCI are honored to be recognized for the significant clinical and financial benefit that KCI products and therapies bring to patients and hospital facilities alike,” said Jim Cunniff, senior vice president, Americas, KCI. “Our mission is simple: to provide transformative healing solutions to those who need it most. This designation affirms that our therapies—in this case, the V.A.C.Ulta™ Therapy System and our Prevena™ System—do indeed offer uniquely beneficial solutions to a broad spectrum of wounds, including the most challenging and complex cases.”
The V.A.C.Ulta™ Therapy System is the latest evolution in V.A.C.® Therapy technology, combining V.A.C.® Therapy with V.A.C. VeraFlo™ Instillation Therapy – the automated, controlled delivery and removal of topical wound solutions in the wound bed. Recent clinical studies indicate that V.A.C. VeraFlo™ Therapy was associated with a statistically significant decrease (p<0.05) in operating room (OR) visits for patients whose infected wounds required hospital admission and serial surgical debridement, when compared to V.A.C.® Therapy.
The Prevena™ Incision Management System is the first and only powered negative pressure product designed specifically for surgical incision management. The Prevena™ System has been associated with positive clinical outcomes when compared to standard of care incision management in published studies covering a variety of incision types, including standard orthopedic, cardiothoracic, vascular procedures and colorectal.
“In addition to evaluating new technologies not on contract, we are pleased to recognize products already on contract that meet the strenuous hospital member-based requirements to be considered through the Innovative Technology program,” said Debbie Archer, director, procurement and innovative technology, Novation.
About KCI
Kinetic Concepts, Inc. (KCI) is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology transformational healing solutions for customers and patients in more than 65 countries around the world. KCI, along with LifeCell Corporation and Systagenix Wound Management, form one globally diversified wound care, biologics and regenerative medicine company, committed to advancing the science of medicine to reduce complications, speed healing and improve patient lives. Headquartered in San Antonio, Texas, the company is a leader in the medical technology industry with the most comprehensive offering of best-in-class surgical and chronic wound therapies. Additional information about KCI and its products is available at www.KCI1.com.
About Novation, Winner of the Ethics Inside Certification
Founded in 1998, Novation is the leading healthcare supply chain expertise, analytics and contracting company for the more than 100,000 members and affiliates of VHA Inc. and UHC, two national health care alliances, Children’s Hospital Association, an alliance of the nation’s leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, and Provista members used Novation contracts to purchase approximately $43 billion in 2012. Novation has earned the coveted Ethics Inside Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance. Novation also was named on Ethisphere’s World’s Most Ethical Companies list and is the only company in the health care industry to earn both distinctions for two consecutive years. To learn more about Novation, please visit www.novationco.com and follow @NovationNews.
